298 related articles for article (PubMed ID: 29625602)
21. Interval cancers in a French breast cancer-screening programme (Somme Department).
Ganry OF; Peng J; Raverdy NL; Dubreuil AR
Eur J Cancer Prev; 2001 Jun; 10(3):269-74. PubMed ID: 11432715
[TBL] [Abstract][Full Text] [Related]
22. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.
Corsetti V; Houssami N; Ghirardi M; Ferrari A; Speziani M; Bellarosa S; Remida G; Gasparotti C; Galligioni E; Ciatto S
Eur J Cancer; 2011 May; 47(7):1021-6. PubMed ID: 21211962
[TBL] [Abstract][Full Text] [Related]
23. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
24. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
[TBL] [Abstract][Full Text] [Related]
25. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
Miller AB; Baines CJ; To T; Wall C
CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
[TBL] [Abstract][Full Text] [Related]
26. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group.
Møller P; Reis MM; Evans G; Vasen H; Haites N; Anderson E; Steel CM; Apold J; Lalloo F; Maehle L; Preece P; Gregory H; Heimdal K
Dis Markers; 1999 Oct; 15(1-3):179-86. PubMed ID: 10595275
[TBL] [Abstract][Full Text] [Related]
28. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
29. Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes.
Onega T; Goldman LE; Walker RL; Miglioretti DL; Buist DS; Taplin S; Geller BM; Hill DA; Smith-Bindman R
J Med Screen; 2016 Mar; 23(1):31-7. PubMed ID: 26265482
[TBL] [Abstract][Full Text] [Related]
30. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapy.
Barth RJ; Gibson GR; Carney PA; Mott LA; Becher RD; Poplack SP
AJR Am J Roentgenol; 2005 Jan; 184(1):324-9. PubMed ID: 15615996
[TBL] [Abstract][Full Text] [Related]
31. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer incidence: Decreasing trend in large tumours in women aged 50-74.
Molinié F; Delacour-Billon S; Tretarre B; Delafosse P; Seradour B; Colonna M
J Med Screen; 2017 Dec; 24(4):189-194. PubMed ID: 27810986
[TBL] [Abstract][Full Text] [Related]
33. The role of mammography screening attendance and detection mode in predicting breast cancer survival-is there added prognostic value?
Biesheuvel C; Czene K; Orgeás CC; Hall P
Cancer Epidemiol; 2011 Dec; 35(6):545-50. PubMed ID: 21470933
[TBL] [Abstract][Full Text] [Related]
34. Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II.
Puvanesarajah S; Gapstur SM; Patel AV; Sherman ME; Flanders WD; Gansler T; Troester MA; Gaudet MM
Breast Cancer Res Treat; 2019 Oct; 177(3):679-689. PubMed ID: 31264062
[TBL] [Abstract][Full Text] [Related]
35. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.
Chiarelli AM; Edwards SA; Sheppard AJ; Mirea L; Chong N; Paszat L; Shumak RS; Oʼmalley FP;
Eur J Cancer Prev; 2012 Nov; 21(6):499-506. PubMed ID: 22273849
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer screening: Impact on care pathways.
Lefeuvre D; Catajar N; Le Bihan Benjamin C; Ifrah N; De Bels F; Viguier J; Bousquet PJ
Cancer Med; 2019 Jul; 8(8):4070-4078. PubMed ID: 31172693
[TBL] [Abstract][Full Text] [Related]
37. Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival.
Porter GJ; Evans AJ; Cornford EJ; Burrell HC; James JJ; Lee AH; Chakrabarti J
AJR Am J Roentgenol; 2007 Mar; 188(3):676-83. PubMed ID: 17312053
[TBL] [Abstract][Full Text] [Related]
38. Impact of screening on breast cancer detection. Retrospective comparative study of two periods ten years apart.
Aubard Y; Genet D; Eyraud JL; Clavère P; Tubiana-Mathieu N; Philippe HJ
Eur J Gynaecol Oncol; 2002; 23(1):37-41. PubMed ID: 11876389
[TBL] [Abstract][Full Text] [Related]
39. Breast density and breast cancer-specific survival by detection mode.
van der Waal D; Verbeek ALM; Broeders MJM
BMC Cancer; 2018 Apr; 18(1):386. PubMed ID: 29618328
[TBL] [Abstract][Full Text] [Related]
40. Improved prognosis of women aged 75 and older with mammography-detected breast cancer.
Malmgren JA; Parikh J; Atwood MK; Kaplan HG
Radiology; 2014 Dec; 273(3):686-94. PubMed ID: 25093690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
